{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-023698","form_type":"8-K","ticker":"PDSB","cik":"0001472091","company_name":"PDS Biotechnology Corp","filed_at":"2026-06-02T19:35:05+00:00","discovered_at":"2026-06-02T19:36:00.589808+00:00","generated_at":"2026-06-02T19:36:07.202296+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"PDS Biotech regains Nasdaq minimum bid price compliance as of June 2, 2026","bullets":["Nasdaq notified PDS Biotech on June 2, 2026 that it regained compliance with the $1.00 minimum bid price rule.","The company had fallen below $1.00 for 30 consecutive business days, triggering a deficiency letter on Feb 25, 2026.","Nasdaq has closed the matter; no further compliance actions required for this issue."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-023698","json":"https://secwatch.observer/filing/0001140361-26-023698.json","markdown":"https://secwatch.observer/filing/0001140361-26-023698.md","text":"https://secwatch.observer/filing/0001140361-26-023698.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/0001140361-26-023698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/ef20075449_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T19:36:07.202296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}